Amrubicin therapy improves patients with refractory small-cell lung cancer: A single-arm confirmatory Chinese clinical study. (2016). Bangladesh Journal of Pharmacology, 11(3), 564-569. https://doi.org/10.3329/bjp.v11i3.23953